SpliceBio
Aniz Girach currently serves as the Chief Medical Officer at SpliceBio and holds the position of Board Director at Sensorion and Panangium Therapeutics. Additionally, Aniz is an Honorary/Visiting Professor of Ophthalmology at Wills Eye Hospital in Philadelphia. Previous roles include Chief Medical Officer at ProQR Therapeutics NV and NIGHTSTAR THERAPEUTICS, Global Head of Ophthalmology at Oxurion NV, Vice President of International Clinical Development in Ophthalmology at Alcon, and Executive Medical Director and Global Head of Ophthalmology at Merck. Aniz has been involved in various leadership capacities in the biotech and pharmaceutical sectors since 2005.
This person is not in any teams
This person is not in any offices
SpliceBio
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.